The FY2024 (Dec) proxy of Seres Therapeutics names 18 peer companies for pay. Pay versus performance data of Seres Therapeutics for that year is not on file, so it has no rank.
Pay peer group, FY2024 (Dec) proxy
| Mirum Pharmaceuticals | ||
| Travere Therapeutics | ||
| Atea Pharmaceuticals | ||
| Arcutis Biotherapeutics | ||
| Enanta Pharmaceuticals | ||
| Amylyx Pharmaceuticals | Not disclosed | Not disclosed |
| Ardelyx | Not disclosed | Not disclosed |
| Atara Biotherapeutics Inc. | Not disclosed | Not disclosed |
| Chinook Therapeutics, Inc. | Not disclosed | Not disclosed |
| Collegium Pharmaceutical | Not disclosed | Not disclosed |
| Crinetics Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Deciphera Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| ImmunoGen, Inc. | Not disclosed | Not disclosed |
| Ironwood Pharmaceuticals | Not disclosed | Not disclosed |
| Karyopham Therapeutics, Inc. | Not disclosed | Not disclosed |
| Macrogenics | Not disclosed | Not disclosed |
| Revance Therapeutics, Inc. | Not disclosed | Not disclosed |
| Rhythm Pharmaceuticals | Not disclosed | Not disclosed |
;}%20.st1{fill-rule:evenodd;clip-rule:evenodd;fill:%23666868;}%20.st2{fill:%2399C13C;}%20.st3{fill:%237A9E3F;}%20.st4{fill:%23BED63A;}%20.st5{fill:%23666868;}%3c/style%3e%3cg%3e%3cdefs%3e%3crect%20id='SVGID_1_'%20x='4.7'%20y='3.6'%20width='241.2'%20height='53'/%3e%3c/defs%3e%3cclipPath%20id='SVGID_00000066476568263475870400000002741637092662773422_'%3e%3cuse%20xlink:href='%23SVGID_1_'%20style='overflow:visible;'/%3e%3c/clipPath%3e%3cg%20id='Group_6'%20transform='translate(0%200)'%20style='clip-path:url(%23SVGID_00000066476568263475870400000002741637092662773422_);'%3e%3cpath%20id='Path_1'%20class='st1'%20d='M85.4,32.4c-0.8-0.9-1.9-1.5-3.1-1.6c-1.8,0-3.2,1.1-6,4.6v-4h-4.2v23.8h4.2V41%20c2.2-4,4-6.1,5.4-6.1c0.4,0,0.8,0.2,1.6,0.9l0.1,0.1L85.4,32.4L85.4,32.4z%20M95.7,30.7c-6.5,0-11.8,5.6-11.8,12.5%20c0,6.8,5.4,12.5,11.8,12.5c6.3,0,11.7-5.7,11.7-12.5C107.4,36.3,102.2,30.7,95.7,30.7%20M95.7,52c-4,0-7.2-3.9-7.2-8.8%20s3.2-8.8,7.2-8.8c4,0,7.2,3.9,7.2,8.8S99.7,52,95.7,52%20M63.6,55.1h4.5V20.6h-4.5V55.1z%20M231.7,17v15.2c-1.6-1.1-3.5-1.6-5.5-1.5%20c-7,0-12.1,5.5-12.1,13.2c0,7,4.1,11.9,9.9,11.9c2.9,0,5.7-1.3,7.6-3.4v2.7h4.2V17H231.7z%20M231.7,47.8c-0.7,0.9-1.5,1.8-2.5,2.5%20c-1.3,1-2.9,1.5-4.5,1.6c-3.6,0-6.1-3.4-6.1-8c0-5.5,3.2-9.1,8-9.1c2.4,0,3.9,0.7,4.6,1.9c0.4,0.8,0.5,1.3,0.5,3L231.7,47.8z%20M200.4,30.7c-6.5,0-11.8,5.6-11.8,12.5c0,6.8,5.4,12.5,11.8,12.5c6.3,0,11.7-5.7,11.7-12.5C212.1,36.3,206.8,30.7,200.4,30.7%20M200.4,52c-4,0-7.2-3.9-7.2-8.8s3.2-8.8,7.2-8.8c4,0,7.2,3.9,7.2,8.8S204.4,52,200.4,52%20M175.3,30.7c-6.5,0-11.8,5.6-11.8,12.5%20c0,6.8,5.4,12.5,11.8,12.5c6.3,0,11.7-5.7,11.7-12.5C187,36.3,181.7,30.7,175.3,30.7%20M175.3,52c-4.1,0-7.2-3.9-7.2-8.8%20s3.2-8.8,7.2-8.8c4,0,7.2,3.9,7.2,8.8S179.3,52,175.3,52%20M123.1,30.7c-2.3,0-4.6,0.9-6.4,2.4c-1.1,0.9-2.1,1.9-3,2.9v-4.7h-4.2%20v23.8h4.2V40.7c4-4.5,6.5-6.2,8.9-6.2c0.9-0.1,1.8,0.4,2.3,1.2c0.3,0.9,0.4,1.8,0.3,2.7v16.8h4.2V37.4%20C129.5,32.9,127.4,30.7,123.1,30.7%20M160.5,31.3c0,0-5.6,18-5.8,18.5c-0.8-2.4-6.1-18.4-6.1-18.4l0-0.1h-4.4c0,0,1.6,4.1,1.6,4.2%20c0,0.1-5,13.8-5.2,14.3c-0.7-2.3-5.6-18.5-5.6-18.5l0-0.1h-4.6l7.9,24.4h3.5l5.6-14.8c0,0,0.1-0.4,0.2-0.8l0.2,0.8%20c0,0,5.3,14.8,5.3,14.8h3.4l8.2-24.4L160.5,31.3z'/%3e%3cpath%20id='Path_2'%20class='st2'%20d='M24.2,55.1c0.2-6.8-1.5-13.5-4.9-19.4C15.8,29.7,10.8,24.6,4.8,21c-0.2,6.8,1.5,13.5,4.9,19.4%20C13.1,46.5,18.2,51.5,24.2,55.1'/%3e%3cpath%20id='Path_3'%20class='st3'%20d='M30.9,56.6c2.2-9.5,1.8-19.4-1.3-28.6c-3.2-9.4-8.8-17.8-16.3-24.4c-2.2,9.5-1.8,19.4,1.3,28.6%20C17.8,41.6,23.4,50,30.9,56.6'/%3e%3cpath%20id='Path_4'%20class='st4'%20d='M38.7,55.1c5.8-5.1,10.1-11.7,12.5-19c2.3-7.2,2.6-14.9,0.8-22.2c-5.8,5.1-10.1,11.7-12.5,19%20C37.2,40.1,36.9,47.8,38.7,55.1'/%3e%3cpath%20id='Path_5'%20class='st5'%20d='M242.6,23.6c-1.9,0-3.4-1.5-3.4-3.4c0-1.9,1.5-3.4,3.4-3.4c1.9,0,3.4,1.5,3.4,3.4%20C246,22,244.5,23.6,242.6,23.6%20M242.6,17.3c-1.6,0-2.9,1.3-2.9,2.9s1.3,2.9,2.9,2.9c1.6,0,2.9-1.3,2.9-2.9c0,0,0,0,0,0%20C245.5,18.6,244.2,17.3,242.6,17.3%20M243.5,22.1l-1.2-1.6h-0.4v1.6h-0.7v-3.9h1.4c1,0,1.5,0.3,1.5,1.1c0,0.6-0.4,1.1-1,1.1%20c0,0,0,0,0,0l1.3,1.7L243.5,22.1z%20M243.1,18.8c-0.2-0.1-0.4-0.1-0.6-0.1h-0.6V20h0.6c0.6,0,0.9-0.2,0.9-0.7%20C243.4,19.1,243.3,18.9,243.1,18.8'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
18 companies
Changes by year
FY2025 (Dec) proxy
- AddedAVROBIOpay peer groupGiven these changes in peer company profiles, Alpine recommended and, in October 2024, the Compensation and Talent Committee approved, the removal of seventeen companies and the addition of nineteen new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedAcrivon Therapeuticspay peer groupGiven these changes in peer company profiles, Alpine recommended and, in October 2024, the Compensation and Talent Committee approved, the removal of seventeen companies and the addition of nineteen new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedAdicet Biopay peer groupGiven these changes in peer company profiles, Alpine recommended and, in October 2024, the Compensation and Talent Committee approved, the removal of seventeen companies and the addition of nineteen new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedAura Biosciencespay peer groupGiven these changes in peer company profiles, Alpine recommended and, in October 2024, the Compensation and Talent Committee approved, the removal of seventeen companies and the addition of nineteen new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedBlack Diamond Therapeuticspay peer groupGiven these changes in peer company profiles, Alpine recommended and, in October 2024, the Compensation and Talent Committee approved, the removal of seventeen companies and the addition of nineteen new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedC4 Therapeuticspay peer groupGiven these changes in peer company profiles, Alpine recommended and, in October 2024, the Compensation and Talent Committee approved, the removal of seventeen companies and the addition of nineteen new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedCartesian Therapeuticspay peer groupGiven these changes in peer company profiles, Alpine recommended and, in October 2024, the Compensation and Talent Committee approved, the removal of seventeen companies and the addition of nineteen new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedEnanta Pharmaceuticalspay peer groupGiven these changes in peer company profiles, Alpine recommended and, in October 2024, the Compensation and Talent Committee approved, the removal of seventeen companies and the addition of nineteen new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedKyvema Therapeuticspay peer groupGiven these changes in peer company profiles, Alpine recommended and, in October 2024, the Compensation and Talent Committee approved, the removal of seventeen companies and the addition of nineteen new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedLarimar Therapeuticspay peer groupGiven these changes in peer company profiles, Alpine recommended and, in October 2024, the Compensation and Talent Committee approved, the removal of seventeen companies and the addition of nineteen new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedPepGenpay peer groupGiven these changes in peer company profiles, Alpine recommended and, in October 2024, the Compensation and Talent Committee approved, the removal of seventeen companies and the addition of nineteen new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedPrime Medicinepay peer groupGiven these changes in peer company profiles, Alpine recommended and, in October 2024, the Compensation and Talent Committee approved, the removal of seventeen companies and the addition of nineteen new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedPyxis Oncologypay peer groupGiven these changes in peer company profiles, Alpine recommended and, in October 2024, the Compensation and Talent Committee approved, the removal of seventeen companies and the addition of nineteen new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedRegulus Therapeuticspay peer groupGiven these changes in peer company profiles, Alpine recommended and, in October 2024, the Compensation and Talent Committee approved, the removal of seventeen companies and the addition of nineteen new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedVentryx Biosciencespay peer groupGiven these changes in peer company profiles, Alpine recommended and, in October 2024, the Compensation and Talent Committee approved, the removal of seventeen companies and the addition of nineteen new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedVoyager Therapeuticspay peer groupGiven these changes in peer company profiles, Alpine recommended and, in October 2024, the Compensation and Talent Committee approved, the removal of seventeen companies and the addition of nineteen new peer companies that better aligned with the Company’s profile to form the following compensation peer group
FY2024 (Dec) proxy
- AddedEnanta Pharmaceuticalspay peer groupGiven these changes in peer company profiles, Alpine recommended and, in August 2023, the Compensation and Talent Committee approved, the removal of three companies and the addition of five new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedIronwood Pharmaceuticalspay peer groupGiven these changes in peer company profiles, Alpine recommended and, in August 2023, the Compensation and Talent Committee approved, the removal of three companies and the addition of five new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedMirum Pharmaceuticalspay peer groupGiven these changes in peer company profiles, Alpine recommended and, in August 2023, the Compensation and Talent Committee approved, the removal of three companies and the addition of five new peer companies that better aligned with the Company’s profile to form the following compensation peer group
FY2023 (Dec) proxy
- AddedAlbireo Pharma Inc.pay peer groupGiven these changes in peer company profiles, Aon recommended and, in September 2022, the Compensation and Talent Committee approved, the removal of nine companies (two of which were acquired) and the addition of eight new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedAmylyx Pharmaceuticalspay peer groupGiven these changes in peer company profiles, Aon recommended and, in September 2022, the Compensation and Talent Committee approved, the removal of nine companies (two of which were acquired) and the addition of eight new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedArcutis Biotherapeuticspay peer groupGiven these changes in peer company profiles, Aon recommended and, in September 2022, the Compensation and Talent Committee approved, the removal of nine companies (two of which were acquired) and the addition of eight new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedAtara Biotherapeutics Inc.pay peer groupGiven these changes in peer company profiles, Aon recommended and, in September 2022, the Compensation and Talent Committee approved, the removal of nine companies (two of which were acquired) and the addition of eight new peer companies that better aligned with the Company’s profile to form the following compensation peer group
- AddedChinook Therapeutics, Inc.pay peer groupGiven these changes in peer company profiles, Aon recommended and, in September 2022, the Compensation and Talent Committee approved, the removal of nine companies (two of which were acquired) and the addition of eight new peer companies that better aligned with the Company’s profile to form the following compensation peer group
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.